Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Feb;25(2):141–148. doi: 10.1136/jcp.25.2.141

Serum hydroxybutyrate dehydrogenase (HBD) assays in the clinical laboratory

K Montazemi 1, J G Lines 1
PMCID: PMC477244  PMID: 5017443

Abstract

Measurement of serum hydroxybutyrate dehydrogenase (HBD) activity for suspected myocardial infarction will nowadays usually be carried out with a commercially available test kit. Four such kits have been compared and evaluated: British Drug Houses HBDH set, Boehringer Corporation LDH-1-Iso-enzyme `α-HBDH' kit, Calbiochem α-HBDH Statpack, and Eskalab α-HBDH reagent tablets. Of the 100 sera examined, 60 were from patients believed to have suffered a recent myocardial infarction, and 40 samples were from patients aged between 45 and 65 years who had no known hepatic, renal, or cardiac pathology, these being used to determine the normal range for each kit. Under standardized conditions the activity found differed from kit to kit; the clinical value of the various assay systems in terms of their ability to discriminate between normal and pathological sera is assessed; and finally the cost and the convenience of use of each kit procedure are discussed. Theoretical and experimental evidence is provided in support of an assay temperature of 30°C, and a plea is made for international agreement on enzyme assay conditions.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMADOR E., DORFMAN L. E., WACKER W. E. SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS. Clin Chem. 1963 Aug;12:391–399. [PubMed] [Google Scholar]
  2. CHINSKY M., WOLFF R. J., SHERRY S. Serum transaminase activity; a comparison of the pyruvic and oxalacetic transaminases. Am J Med Sci. 1957 Apr;233(4):400–408. doi: 10.1097/00000441-195704000-00006. [DOI] [PubMed] [Google Scholar]
  3. DEWAR H. A., ROWELL N. R., SMITH A. J. Serum glutamic oxalacetic transaminase in acute myocardial infarction. Br Med J. 1958 Nov 8;2(5105):1121–1125. doi: 10.1136/bmj.2.5105.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ELLIOTT B. A., WILKINSON J. H. Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet. 1961 Apr 1;1(7179):698–699. doi: 10.1016/s0140-6736(61)91724-x. [DOI] [PubMed] [Google Scholar]
  5. KONTTINEN A., HALONEN P. I. Serum alpha-hydroxybutyric dehydrogenase (HBD) in myocardial infarction. Comparison with glutamic oxalacetic transminase (GOT) and lactic dehydrogenase (LDH). Am J Cardiol. 1962 Oct;10:525–531. doi: 10.1016/0002-9149(62)90377-6. [DOI] [PubMed] [Google Scholar]
  6. KONTTINEN A. alpha-Hydroxybutyric dehydrogenase in the detection of myocardial infarction. Lancet. 1961 Sep 2;2(7201):556–556. doi: 10.1016/s0140-6736(61)92994-4. [DOI] [PubMed] [Google Scholar]
  7. LADUE J. S., WROBLEWSKI F., KARMEN A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954 Sep 24;120(3117):497–499. doi: 10.1126/science.120.3117.497. [DOI] [PubMed] [Google Scholar]
  8. PAGLIARO L., NOTARBARTOLO A. Alpha-Hydroxybutyric dehydrogenase in the diagnosis of myocardial infarction. Lancet. 1962 May 19;1(7238):1043–1045. doi: 10.1016/s0140-6736(62)92144-x. [DOI] [PubMed] [Google Scholar]
  9. PLUMMER D. T., WILKINSON J. H. Organ specificity and lactatedehydrogenase activity. 2. Some properties of human-heart and liver preparations. Biochem J. 1963 May;87:423–429. doi: 10.1042/bj0870423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PRESTON J. A., BATSAKIS J. G., BRIERE R. O. SERUM "ALPHA-HYDROXYBUTYRATE DEHYDROGENASE". A CLINICAL AND LABORATORY EVALUATION IN PATIENTS WITH MYOCARDIAL INFARCT. Am J Clin Pathol. 1964 Mar;41:237–243. doi: 10.1093/ajcp/41.3.237. [DOI] [PubMed] [Google Scholar]
  11. ROSALKI S. B. SERUM ALPHA-HYDROXYBUTYRATE DEHYDROGENASE: A NEW TEST FOR MYOCARDIAL INFARCTION. Br Heart J. 1963 Nov;25:795–802. doi: 10.1136/hrt.25.6.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ROSALKI S. B., WILKINSON J. H. Reduction of alpha-ketobutyrate by human serum. Nature. 1960 Dec 24;188:1110–1111. doi: 10.1038/1881110a0. [DOI] [PubMed] [Google Scholar]
  13. STUART J., CRAWFORD I. C., FORSHALL J., OWEN J. A. SERUM HYDROXYBUTYRATE DEHYDROGENASE IN MYOCARDIAL INFARCTION. Br Med J. 1965 Feb 13;1(5432):423–425. doi: 10.1136/bmj.1.5432.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES